Gerhard F. Burbach - 12 May 2025 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Role: Director
Signature: /s/ Jeremy Hayden, Attorney-in-Fact for Gerhard F. Burbach
Issuer symbol: SGHT
Transactions as of: 12 May 2025
Net transactions value: $0
Form type: 4
Filing time: 14 May 2025, 21:20:54 UTC
Previous filing: 06 May 2025
Next filing: 09 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Burbach Gerhard F	Director	C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK	/s/ Jeremy Hayden, Attorney-in-Fact for Gerhard F. Burbach	14 May 2025	0001307313

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGHT	Common Stock	Award	$0	+74,766	+374%	$0.000000	94,766	12 May 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $240,000 of shares of Common Stock as determined by the closing price on the grant date, May 12, 2025. The RSUs vest in substantially equal installments on each of May 12, 2026, 2027, and 2028, subject to the Reporting Person's continued service as a director on the Company's board of directors through each such vesting date.

Content

Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $240,000 of shares of Common Stock as determined by the closing price on the grant date, May 12, 2025. The RSUs vest in substantially equal installments on each of May 12, 2026, 2027, and 2028, subject to the Reporting Person's continued service as a director on the Company's board of directors through each such vesting date.